January 11, 2012
Ronald Shapiro MD, PhD, FACP
Clinical Associate Professor of Medicine, University of Toledo
Toxic Joint Syndrome (TJS) was defined and characterized in the first segment of this series. Certainly there are benefits to current therapeutic options; however, there are also significant disadvantages that include treatment associated morbidity and mortality, reduced quality of life, impaired performance, income loss from escalating debility, and significant moneta...